Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

GLN-NINTEDANIB DIN 02569248

Status: Approved
Holder: GLENMARK PHARMACEUTICALS CANADA INC.
Molecule: NINTEDANIB (NINTEDANIB ESILATE)
Available to quote

Health Canada record

Active ingredient(s)NINTEDANIB (NINTEDANIB ESILATE) 150 MG
Dosage formCapsule
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCL01EX09 NINTEDANIB
Original market date
Current status date22-Jun-2026
SourceHealth Canada DPD

Establishment licence of the holder

Glenmark Pharmaceuticals Canada Inc. — licence 102261, currently licensed, last inspection rating C (2024-05-14).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing NINTEDANIB (NINTEDANIB ESILATE)

DINProductCompanyFormStrengthStatus
02526891AURO-NINTEDANIBAURO PHARMA INCCapsuleNINTEDANIB (NINTEDANIB ESILATE) 100 MGMarketed
02526905AURO-NINTEDANIBAURO PHARMA INCCapsuleNINTEDANIB (NINTEDANIB ESILATE) 150 MGMarketed
02547538EUGIA-NINTEDANIBEUGIA PHARMA INC.CapsuleNINTEDANIB (NINTEDANIB ESILATE) 150 MGApproved
02547511EUGIA-NINTEDANIBEUGIA PHARMA INC.CapsuleNINTEDANIB (NINTEDANIB ESILATE) 100 MGApproved
02569221GLN-NINTEDANIBGLENMARK PHARMACEUTICALS CANADA INC.CapsuleNINTEDANIB (NINTEDANIB ESILATE) 100 MGApproved
02540762JAMP NINTEDANIBJAMP PHARMA CORPORATIONCapsuleNINTEDANIB (NINTEDANIB ESILATE) 150 MGMarketed
02550849JAMP NINTEDANIBJAMP PHARMA CORPORATIONCapsuleNINTEDANIB (NINTEDANIB ESILATE) 100 MGMarketed
02443066OFEVBOEHRINGER INGELHEIM (CANADA) LTD LTEECapsuleNINTEDANIB (NINTEDANIB ESILATE) 100 MGMarketed
02443074OFEVBOEHRINGER INGELHEIM (CANADA) LTD LTEECapsuleNINTEDANIB (NINTEDANIB ESILATE) 150 MGMarketed

Notices of Compliance

NOCDateSubmissionReason
377562026-06-22Abbreviated New Drug Submission (ANDS)
Request a quote for GLN-NINTEDANIB

How to read a Canadian DIN record